Join to View Full Profile
303 E Superior Lurie 4-107Chicago, IL 60610
Phone+1 312-503-4853
Dr. Matei is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
UCLA David Geffen School of Medicine/UCLA Medical CenterFellowship, Hematology and Medical Oncology, 1999 - 2002
Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1997 - 1999- Stony Brook Medicine/University HospitalResidency, Internal Medicine, 1993 - 1996
Carol Davila University of Medicine and PharmacyClass of 1992
Certifications & Licensure
CA State Medical License 1996 - Present
IL State Medical License 2015 - 2026
IN State Medical License 2002 - 2017
American Board of Internal Medicine Medical Oncology
Clinical Trials
- Irinotecan Liposome and Bevacizumab for the Treatment of Platinum Resistant, Recurrent, or Refractory Ovarian, Fallopian Tube, or Primary Peritoneal Cancer Start of enrollment: 2021 Mar 16
Roles: Contact, Principal Investigator
Publications & Presentations
PubMed
- 1 citationsLong-Term Follow-Up and Overall Survival in NRG258, a Randomized Phase III Trial of Chemoradiation Versus Chemotherapy for Locally Advanced Endometrial Carcinoma.Daniela E Matei, Danielle M Enserro, Marcus E Randall, David Mutch, William Small
Journal of Clinical Oncology. 2025-03-20 - Chromatin Organization Governs Transcriptional Response and Plasticity of Cancer Stem Cells.Yinu Wang, Jane Frederick, Karla Isabel Medina, Elizabeth Thomas Bartom, Luay Matthew Almassalha
Advanced Science. 2025-03-07 - Complement activation at the interface between adipocytes and cancer cells drives tumor progression.Andres Valdivia, Ana Maria Isac, Horacio Cardenas, Guangyuan Zhao, Yaqi Zhang
JCI Insight. 2025-02-18
Press Mentions
HMN 2025: What Is the Brand New Goal for RemedyApril 1st, 2025- Understanding How Cancer Cells Adapt to Evade TreatmentMarch 28th, 2025
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
